LAB282
  • Home
  • About
    • LAB282
    • Funded Projects
    • IP & Commercialisation
    • LAB282 Support
  • Applications
    • Applying to LAB282
    • Application FAQs
  • Team
    • Partners
    • Steering Committee
    • Industry Experts
    • OUI Support
  • Case Studies
    • Myelofibrosis
    • Myocarditis
    • Next-Generation Antibiotics
  • News
  • Contact
Select Page

Lab282 Partners

LAB282 is a partnership between the University of Oxford, Oxford University Innovation Ltd, Oxford Sciences Innovation plc (OSI) and Evotec AG, created to identify and develop new approaches to treating disease.

Privacy Policy | Cookie Policy

© LAB282 2021. All rights reserved